The 2.3 percent medical device tax, originally implemented as a piece of the Affordable Care Act, is currently suspended until 2020. Could 2019 be the year it gets repealed for good?

More than 40 percent of hospitals and other healthcare providers believe 3M’s $1 billion acquisition of M*Modal will have an overall positive impact in the market, according to a survey by Reaction Data.

It isn’t too late to sustain a 50-year-long reduction in cardiovascular disease-related deaths, according to research published in Clinical Cardiology—but with rising rates of obesity and diabetes, we’re closer than ever to reversing that progress.

Clearwater Compliance and Digital Reasoning have announced a three-year “Cyber Risk Services” partnership enabling providers to understand the results of AI-powered solutions, using a cybersecurity and HIPAA compliance program.

The department of radiology and biomedical imaging at the University of California, San Francisco (UCSF) announced this week that the large expansion of one of its imaging facilities is now complete.

The Protecting Access to Medicare Act (PAMA) mandating the use of a clinical decision support (CDS) system when ordering advanced imaging tests could affect up to six million emergency department visits annually, according to estimates published in a Jan. 29 Radiology study. The law is set to go into effect in January 2020.

David F. Torchiana, MD, CEO of Boston-based Partners HealthCare, has announced his plans to retire, The Boston Globe reported. 

The FDA announced that it approved 106 novel medical devices in 2018, surpassing the previous record of 98 set just one year prior. Nine devices also received the agency’s Breakthrough Device Designation.